Previous close | 0.1000 |
Open | 0.1000 |
Bid | 0.0000 |
Ask | 1.3500 |
Strike | 47.50 |
Expiry date | 2024-05-17 |
Day's range | 0.1000 - 0.1000 |
Contract range | N/A |
Volume | |
Open interest | 237 |
Although the revenue and EPS for Baxter (BAX) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Baxter (BAX) reports better-than-expected first-quarter earnings and sales. BAX's quarterly results reflect solid demand for a range of its medically essential products.
Robust Operational Performance Drives Growth Amidst Strategic Transformations